After GMR, Indian carmakers in deep waters in Sri Lanka

December 12, 2012

car_copy

New Delhi, Dec 12: After the Maldives, India’s economic interests are in deep waters in another neighbouring island nation, Sri Lanka.

 

Notwithstanding the setback in its efforts to help the GMR Group in the Maldives, New Delhi has now taken up the cudgels for Indian carmakers and urged Colombo to roll back the recent steep hikes in import duty on automobiles.

 

“The Indian High Commission in Colombo has taken up the matter with the Sri Lankan government. The issue will be discussed again when the Finance Secretary of Sri Lanka would travel to India,” said Syed Akbaruddin, Spokesperson of the Ministry of External Affairs (MEA), on Tuesday. Sri Lankan finance secretary Dr P B Jayasundera is set to visit India shortly.

 

The Sri Lankan government recently raised excise duty on imported utility vehicles from 100 per cent to 173 per cent. Duty on cars with less than 1000 cc engines was also raised from 120 per cent to 200 per cent, including a 47 per cent hike in excise duty.

 

The excise duty on both three-wheelers and two-wheelers were raised from 45 per cent and 61 per cent respectively to 100 per cent. Besides, an absolute levy of $ 845.95 was imposed on all commercial vehicles, in addition to an 12 per cent excise duty. Indian carmakers would be hit hard by the steep hike as the island nation is the largest export market, accounting to nearly 13 per cent of the total automobile export.

 

The Ministry of Commerce is understood to have sought the help of the MEA to take up the issue diplomatically with the Sri Lankan government.

 

Rajiv Kher, additional secretary in the Ministry of Commerce, on Monday said that New Delhi was concerned over the “very substantial rise in import tariff” by Sri Lank as the island nation on the Indian Ocean was a “very important market” for cars and commercial vehicles manufactured in India.

 

Lately, New Delhi has reacted very strongly to the Maldivian government’s decision to terminate its agreement with a consortium led by Indian infrastructure giant GMR Group to manage the international airport in an island close to the archipelagic nation’s capital Male. New Delhi warned Maldives about the repercussions their move could have on bilateral ties.

 

But a judgment of the Court of Appeal of Singapore on December 6 ruled that the Maldivian government could take control of the airport from the GMR Male International Airport Limited or GMIAL, a joint venture of GMR Infrastructure and Malaysia Airports Holding Berhad.

 

The judgment came as a setback for the GMR Group that had earlier got an injunctive relief from the High Court of Singapore against the applicability and operations of the notice the Maldivian government had served the company on November 27 seeking to take back the control of the airport. India subtly toned down its rhetoric on Maldives move against GMIAL after the judgment.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 8,2020

New Delhi, Jul 8: India has reported a spike of 22,752 COVID-19 cases in the last 24 hours, taking the country's coronavirus tally to 7,42,417 on Wednesday, informed the Union Ministry of Health and Family Welfare.

Out of the total cases reported, 4,56,830 patients have been cured/discharged from the disease while one patient has been migrated, the Health Ministry informed.

It added that there are 2,64,944 active cases in the country.

482 deaths reported in the last 24 hours due to COVID-19 in the country, taking India's death toll to 20,642.

According to the Union Health Ministry, Maharashtra continues to be the worst affected state reporting 2,17,121 coronavirus cases and 9,250 fatalities.

Tamil Nadu -- the second worst-affected state from COVID-19 -- has a total of 1,18,594 cases and 1,636 deaths due to coronavirus.

While Delhi has a total of 1,02,831 COVID-19 cases including 3,165 deaths.

The Indian Council of Medical Research on Wednesday informed that a total of 1,04,73,771 samples tested for COVID-19 up to July 7. Of these, 2,62,679 samples were tested on Tuesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 24,2020

New Delhi, Jan 24: Under attack for doling out subsidies, Delhi Chief Minister Arvind Kejriwal on Friday said freebies in limited dose are good for the economy as they make more money available to the poor and boosts demand.

Opposition parties have been attacking the AAP-led Delhi government for giving "freebies" ahead of polls after it announced schemes like free bus rides for women and 200 units of free electricity.

"Freebies, in limited dose, are good for economy. It makes more money available to poor, hence boosts demand. However, it should be done in such limits so that no extra taxes have to be imposed and it does not lead to budget deficits," Kejriwal said in a tweet.

Slamming the BJP, Kejriwal said he is happy that the people of Delhi have forced the Saffron party to ask for votes on the basis of CCTVs, schools and unauthorised colonies.

Reacting to a tweet of the BJP Delhi in which Home Minister Amit Shah had asked how many schools have been constructed and cameras installed by the AAP government, Kejriwal said he is happy that Shah saw some CCTV cameras as earlier he had claimed that he could not find a single one.

"I am happy you saw some CCTV cameras. A few days back you said there was not a single camera. Take out some time we will show you our schools also. I am extremely happy that the people of Delhi have changed the politics by which the BJP has to ask for votes on CCTV, schools and raw colonies here," he said in a tweet.

Responding to Shah's allegation that he could not find WiFi in Delhi as promised by Kejriwal and that his battery drained out in the process, the Delhi chief minister said along with free WiFi they have also made arrangement for free charging points.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.